Read More

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.

AAOI

Read More

Theralink And IMAC Holdings Announce Receipt And Response To The Securities And Exchange Commission Comments On The Previously Filed Form S4; Co’s Expect To Hear Back From The Securities And Exchange Commission Within The Next 10 Business Days

Theralink Technologies, Inc. (OTC:THER) ("Theralink"), a precision oncology company with its exclusive commercial RPPA (reverse phase protein array) technology that can help predict which FDA-approved drug is effective

BACK